Treatment of patients with non-resectable locally advanced rectal cancer (LARC). New treatment strategies for patients with local advanced rectal cancer;Ny behandlingsstrategi for patienter med primær, ikkeresektabel rectumcancer

Ugeskrift for Laeger

Volumn 168, Issue 19, 2006, Pages 1857-1860

  Pfeiffer, Per ^a   Baatrup, Gunnar ^a   Jensen, Helle Anita ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; UFT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MALE; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RECTUM CANCER; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; TEGAFUR; URACIL; VITAMIN B COMPLEX;

EID: 33646520345     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kronborg O, Jakobsen AK. Cancer recti. Ugeskr Læger 2002;164:3046-8.
2. Harling H, Bülow S, Kronborg O et al. Behandling af cancer recti i Danmark 1994-1999. Ugeskr Læger 2004;166:368-71.
3. Glimelius B. Chemoradiotherapy for rectal cancer - is there an optimal combination? Ann Oncol 2001;12:1039-45.
4. Bulow S, Moesgaard FA, Crone PO et al. Recidiv og overlevelse efter konventionel lav anterior resektion for cancer recti. Ugeskr Læger 2001;163:3793-7.
5. Kapiteijn E, Marijnen C, Nagtegaal I et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Eng J Med 2001;345:638-46.
6. Gunderson LL. Indications for and results of combined modality treatment of colorectal cancer. Acta Oncol 1999;38:7-21.
7. Overgaard M, Bertelsen K, Dalmark M et al. A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma. Acta Oncol 1993;32:547-53.
8. Pfeiffer P, Jakobsen A. Concurrent UFT/leucovorin and curative intented radiotherapy (60 Gy) in patients with locally advanced rectal cancer (IRRC): a phase I/II trial. Proc Am Soc Clin Oncol 2000:255 (Abstr 992).
9. Mohiuddin M, Regine WF, John WJ et al. Preoperative chemoradiation in fixed distal rectal cancer: Dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883-8.
10. Glimelius B, Isacsson U, Jung B et al. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose response effect favouring pre-operative treatment. Int J Radiat Oncol Biol Phys 1997;37:281-7.
11. Tveit KM. Radiotherapy in Rectal Cancer. Acta Oncol 1999;38:5-6.
12. Minsky BD. UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy. Int J Cancer 2001;96:1-10.
13. Sadahiro S, Suzuki T, Kameya T et al. A pharmacological study of the weekday-on/ weekend-off oral UFT schedule in colorectal cancer patients. Cancer Chemother Pharmacol 2001;47:447-50.
14. Francois Y, Nemoz CJ, Baulieux J et al. Infuence of the interval between pre-operative radiation therapy and surgery on down-staging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396-402.
15. Lauerberg S. Cancer recti-behandling i Danmark - hvordan gør vi det bedre? Ugeskr Læger 2004;166:349.